As shown in Figure 4B, activation of caspase-3 after ENFX or CPFX treatment of the canine OSA cells was confirmed by western blot analysis and the activation of caspase-3 was correlated with the proteolytic cleavage of PARP. Here, CASP3 is linked to obstructive sleep apnea syndrome.